Oragenics Inc
OGEN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001174940
No open-market purchases or sales by Oragenics Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $39.2K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Oragenics Inc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- −17 vs. Q4 2022
- Shares held
- 58.8K
- −112.4K (−65.7%) vs. Q4 2022Converted for a 1-for-60 split
- Total value
- $192.4K
- −$886.7K (−82.2%) vs. Q4 2022
- New holders
- 3
- 7 more added
- Sold out
- 20
- 1 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OGEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $39.2K |
| Q1 2026 | 20 | $105.8K |
| Q4 2025 | 19 | $169.3K |
| Q3 2025 | 16 | $160.5K |
| Q2 2025 | 18 | $401.6K |
| Q1 2025 | 22 | $57.2K |
| Q4 2024 | 24 | $86.0K |
| Q3 2024 | 16 | $62.2K |
| Q2 2024 | 16 | $135.6K |
| Q1 2024 | 14 | $269.2K |
| Q4 2023 | 15 | $349.5K |
| Q3 2023 | 13 | $182.1K |
| Q2 2023 | 13 | $173.5K |
| Q1 2023 | 14 | $192.4K |
| Q4 2022 | 31 | $1.08M |
| Q3 2022 | 29 | $2.48M |
| Q2 2022 | 29 | $3.06M |
| Q1 2022 | 28 | $3.62M |
| Q4 2021 | 33 | $4.96M |
| Q3 2021 | 29 | $6.82M |
| Q2 2021 | 22 | $6.63M |
| Q1 2021 | 29 | $8.27M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Oragenics Inc; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 5 | $0 | 0.00% | +3+191.3% | AddedConverted for a 1-for-60 split |
| Chesapeake Asset Management LLC | 3 | $9 | 0.00% | +3 | New |
| Advisor Group Holdings, Inc. | 6 | $19 | 0.00% | +1+15.0% | AddedConverted for a 1-for-60 split |
| Wells Fargo & Company | 14 | $46 | 0.00% | +1+5.1% | AddedConverted for a 1-for-60 split |
| Wolff Wiese Magana LLC | 17 | $56 | 0.00% | +0+2.0% | AddedConverted for a 1-for-60 split |
| Northwestern Mutual Wealth Management Co | 35 | $115 | 0.00% | +35 | New |
| IFP Advisors, Inc | 102 | $159 | 0.00% | +100+6,020.0% | AddedConverted for a 1-for-60 split |
| Bank of America Corp | 114 | $375 | 0.00% | −1−0.9% | ReducedConverted for a 1-for-60 split |
| Tower Research Capital LLC (TRC) | 1,950 | $6.00K | 0.00% | +592+43.5% | AddedConverted for a 1-for-60 split |
| UBS Group AG | 2,528 | $8.31K | 0.00% | +2,528 | New |
| FMR LLC | 2,597 | $8.54K | 0.00% | 00.0% | UnchangedConverted for a 1-for-60 split |
| Geode Capital Management, LLC | 12,453 | $41.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-60 split |
| Renaissance Technologies LLC | 16,799 | $55.0K | 0.00% | +11,992+249.5% | AddedConverted for a 1-for-60 split |
| BlackRock Inc. | 22,148 | $72.9K | 0.00% | 00.0% | UnchangedConverted for a 1-for-60 split |
| Vanguard Group Inc | 0 | $0 | 0.00% | −84,386−100.0% | Sold outConverted for a 1-for-60 split |
| Sara-Bay Financial | 0 | $0 | 0.00% | −21,188−100.0% | Sold outConverted for a 1-for-60 split |
| State Street Corp | 0 | $0 | 0.00% | −8,259−100.0% | Sold outConverted for a 1-for-60 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −3,023−100.0% | Sold outConverted for a 1-for-60 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −2,449−100.0% | Sold outConverted for a 1-for-60 split |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −2,333−100.0% | Sold outConverted for a 1-for-60 split |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −1,680−100.0% | Sold outConverted for a 1-for-60 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −1,445−100.0% | Sold outConverted for a 1-for-60 split |
| LexAurum Advisors, LLC | 0 | $0 | 0.00% | −833−100.0% | Sold outConverted for a 1-for-60 split |
| Raymond James & Associates | 0 | $0 | 0.00% | −564−100.0% | Sold outConverted for a 1-for-60 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −403−100.0% | Sold outConverted for a 1-for-60 split |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −214−100.0% | Sold outConverted for a 1-for-60 split |
| Newman Dignan & Sheerar, Inc. | 0 | $0 | 0.00% | −174−100.0% | Sold outConverted for a 1-for-60 split |
| Cerity Partners LLC | 0 | $0 | 0.00% | −169−100.0% | Sold outConverted for a 1-for-60 split |
| Strategies Wealth Advisors, LLC | 0 | $0 | 0.00% | −167−100.0% | Sold outConverted for a 1-for-60 split |
| American Financial Group Inc | 0 | $0 | 0.00% | −226−100.0% | Sold outConverted for a 1-for-60 split |
| Spire Wealth Management | 0 | $0 | 0.00% | −111−100.0% | Sold outConverted for a 1-for-60 split |
| Morgan Stanley | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-60 split |
| Corrado Advisors, LLC | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-60 split |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-60 split |